Patents by Inventor Malcolm Johnson

Malcolm Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5373925
    Abstract: An underwater deployment and storage apparatus for a diving bell or the like has a reel assembly (7) with spaced flanges (9,10) to contain an umbilical services assembly (5) wound around a hub (7A) of the reel. A rotary union (12) mounted in the hub has a fixed assembly or static line (11) about which the hub rotates. The fixed assembly receives services such as gases, liquids, electricity, fibre optics and the like and feeds to a rotatable assembly connected with the hub. The umbilical services are coupled to one of the umbilical. A first drive motor rotates the reel in either direction. A second drive motor and fairlead (6) extract from or rewind the umbilical onto the reel. Both drive motors are synchronized under controls to exert and maintain either a tractive or a drag force on the run of the umbilical.
    Type: Grant
    Filed: April 6, 1993
    Date of Patent: December 20, 1994
    Assignee: Ocean Technical Services Limited
    Inventors: Roger J. Handford, Malcolm Johnson
  • Patent number: 5290815
    Abstract: The present invention provides a new medical use for the phenethanolamine compound 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction.
    Type: Grant
    Filed: November 25, 1991
    Date of Patent: March 1, 1994
    Assignee: Glaxo Group Limited
    Inventors: Malcolm Johnson, Clifford J. Whelan
  • Patent number: 5283268
    Abstract: The present invention provides a new medical use for the dichloroaniline 4-amino-3,5-dichloro-.alpha.-[[[6-[2-(2-pyridinyl)ethoxy]hexyl]amino]methy l]benzenemethanol and its enantiomers, and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction.
    Type: Grant
    Filed: March 4, 1992
    Date of Patent: February 1, 1994
    Assignee: Glaxo Group Limited
    Inventors: Malcolm Johnson, Clifford J. Whelan
  • Patent number: 4847255
    Abstract: The use is described of compounds of formula ##STR1## in which n is 1 or 2;m is 2-5 and X is --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; or m is 1-4 and X is --CH.dbd.CH.dbd.CH--;R.sup.1 is phenyl, substituted phenyl or naphthyl;Y is substituted or unsubstituted 3-phenoxy-2-hydroxypropyl, in the therapy or prophylaxis of atherosclerosis and other disorders associated with abnormal levels of blood lipids and serum cholesterol.
    Type: Grant
    Filed: October 21, 1987
    Date of Patent: July 11, 1989
    Assignee: Glaxo Group Limited
    Inventors: Eric W. Collington, Harry Finch, Duncan B. Judd, Malcolm Johnson, Peter Strong
  • Patent number: 4267183
    Abstract: The invention concerns the novel amine 1-(2-chlorobenzyl)-1,2,3,6-tetrahydropyridine of the formula: ##STR1## and its pharmaceutically acceptable acid-addition salts, which have useful properties in inhibiting the aggregation of blood platelets, and are of application in the treatment or propyhylaxis of thrombosis or occlusive vascular disease. The invention also provides pharmaceutical compositions of, and analogy processes for the manufacture of the amine of formula I, or a salt thereof.
    Type: Grant
    Filed: February 7, 1980
    Date of Patent: May 12, 1981
    Assignee: Imperial Chemical Industries Limited
    Inventors: Malcolm Johnson, Stuart D. Mills, Paul J. Phillips
  • Patent number: 4225602
    Abstract: The invention concerns the novel amine 1-(2-chlorobenzyl)-1,2,3,6-tetrahydropyridine of the formula: ##STR1## and its pharmaceutically acceptable acid-addition salts, which have useful properties in inhibiting the aggregation of blood platelets, and are of application in the treatment or prophylaxis of thrombosis or occlusive vascular disease. The invention also provides pharmaceutical compositions of, and analogy processes for the manufacture of the amine of formula I, or a salt thereof.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: September 30, 1980
    Assignee: Imperial Chemical Industries Limited
    Inventors: Malcolm Johnson, Stuart D. Mills, Paul J. Phillips